Niagen Bioscience, Inc. (NAGE)
3.505
+0.14
(+4.01%)
USD |
NASDAQ |
Jun 09, 16:00
3.505
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience SG&A Expense (Quarterly) : 16.92M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| LifeVantage Corp. | 32.87M |
| Cyanotech Corp. | 2.126M |
| Mannatech, Inc. | 19.04M |
| Natural Alternatives International, Inc. | 4.397M |
| USANA Health Sciences, Inc. | 176.91M |